AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Sodexo S.A.

$13.04 +$2.93 (+28.98%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$13.02
Day Range
$13.02$13.09
Year Range
$9.08$13.69
Market Cap
9.51B
AVG Volume
87.44K
Trailing/Forward PE
18.31/19.56
PEG ratio
0.93
Dividend Yield
4.79%
Next Earnings Date
2026-10-23
Primary Exchange
Other OTCUS
Revenue (EUR)
05B10B15B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
SDXAY Revenue (EUR) by quarter
PeriodRevenue (EUR)
26 Q211.93B
25 Q411.25B
25 Q212.47B
24 Q411.7B
24 Q212.1B
23 Q410.55B
23 Q212.09B
22 Q410.86B
22 Q210.26B
21 Q48.83B
Net Income (EUR)
-200M0200M400M600M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
SDXAY Net Income (EUR) by quarter
PeriodNet Income (EUR)
26 Q2186.61M
25 Q4253.21M
25 Q2434M
24 Q4242M
24 Q2-74M
23 Q4354M
23 Q2440M
22 Q4358M
22 Q2337M
21 Q4106M
Operating Income (EUR)
0200M400M600M800M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
SDXAY Operating Income (EUR) by quarter
PeriodOperating Income (EUR)
26 Q2385.12M
25 Q4453.06M
25 Q2629M
24 Q4493M
24 Q2642M
23 Q4250M
23 Q2679M
22 Q4512M
22 Q2535M
21 Q4307M
EBITDA (EUR)
0250M500M750M1B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
SDXAY EBITDA (EUR) by quarter
PeriodEBITDA (EUR)
26 Q2638.23M
25 Q4671.73M
25 Q2845M
24 Q4765M
24 Q2834M
23 Q4419M
23 Q2964M
22 Q4801M
22 Q2805M
21 Q4609M
Cash Flows (EUR)
-500M0500M1B1.5B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
SDXAY Cash Flows (EUR) by quarter
PeriodCash Flows (EUR)
26 Q2-162.78M
25 Q4755.78M
25 Q2-158M
24 Q4825M
24 Q2137M
23 Q41.05B
23 Q283M
22 Q4588M
22 Q2102M
21 Q4419M
EPS (EUR)
-0.200.20.40.621 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
SDXAY EPS (EUR) by quarter
PeriodEPS (EUR)
26 Q20.25
25 Q40.45
25 Q20.59
24 Q40.33
24 Q2-0.1
23 Q40.48
23 Q20.6
22 Q40.48
22 Q20.45
21 Q40.14
Expenses (EUR)
0500M1B1.5BSG&ACapex21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
SDXAY Expenses (EUR) by quarter
PeriodExpenses (EUR)
26 Q21.02B
25 Q4973.4M
25 Q21.04B
24 Q41.05B
24 Q21.05B
23 Q4724M
23 Q21.27B
22 Q41.24B
22 Q21.09B
21 Q41.09B
Cash & Debt (EUR)
02B4B6B8BCashLong Term DebtShort Term Debt21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
SDXAY Cash & Debt (EUR) by quarter
PeriodCash & Debt (EUR)
26 Q21.18B
25 Q42.45B
25 Q21.42B
24 Q42.14B
24 Q21.45B
23 Q42.02B
23 Q22.69B
22 Q43.23B
22 Q22.66B
21 Q44.6B
Debt ratios
012321 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
SDXAY Debt ratios by quarter
PeriodDebt ratios
26 Q21.45
25 Q41.26
25 Q21.46
24 Q41.12
24 Q21.37
23 Q41.46
23 Q21.23
22 Q41.31
22 Q22.12
21 Q41.29
Margins
0%5%10%15%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
SDXAY Margins by quarter
PeriodMargins
26 Q210.61%
25 Q411.13%
25 Q212.06%
24 Q411.71%
24 Q212.19%
23 Q48.97%
23 Q214.37%
22 Q414.43%
22 Q214.32%
21 Q414.06%
Return on Capital
-5%0%5%10%15%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
SDXAY Return on Capital by quarter
PeriodReturn on Capital
26 Q25.16%
25 Q45.69%
25 Q210.8%
24 Q46.37%
24 Q2-1.67%
23 Q47.78%
23 Q210.73%
22 Q48.09%
22 Q29.3%
21 Q43.34%
Shares Outstanding
0200M400M600M800M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
SDXAY Shares Outstanding by quarter
PeriodShares Outstanding
26 Q2727.79M
25 Q4730.21M
25 Q2729.99M
24 Q4732.27M
24 Q2731.45M
23 Q4730.51M
23 Q2730.74M
22 Q4731.49M
22 Q2731.46M
21 Q4730.03M
Dividends (EUR)
0246Feb 18Jan 19Jan 20Dec 21Dec 22Dec 23Mar 24Aug 24Dec 24Dec 25
SDXAY Dividends (EUR) by quarter
PeriodDividends (EUR)
Dec 250.64
Dec 240.55
Aug 241.38
Mar 245.86
Dec 230.67
Dec 220.51
Dec 210.46
Jan 200.65
Jan 190.62
Feb 180.66
Book Value Per Share (EUR)
0246821 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
SDXAY Book Value Per Share (EUR) by quarter
PeriodBook Value Per Share (EUR)
26 Q24.97
25 Q46.09
25 Q25.51
24 Q45.19
24 Q26.06
23 Q46.23
23 Q25.61
22 Q46.05
22 Q24.96
21 Q44.35
Total Assets (EUR)
010B20B30B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
SDXAY Total Assets (EUR) by quarter
PeriodTotal Assets (EUR)
26 Q214.83B
25 Q417.38B
25 Q215.34B
24 Q415.02B
24 Q215.6B
23 Q420.79B
23 Q220.57B
22 Q420.92B
22 Q219.65B
21 Q418.99B
PE Ratio
68101214med 7.99Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SDXAY PE Ratio by quarter
PeriodPE Ratio
Sep 267.33
Sep 267.53
Aug 267.6
Aug 267.31
Aug 267.35
Aug 267.44
Jul 267.44
Jul 267.2
Jul 267.07
Jul 266.86
Jul 266.97
Jun 266.63
Jun 266.8
Jun 266.55
Jun 266.48
May 266.19
May 267.82
May 268.08
May 267.29
May 267.47
Apr 267.42
Apr 267.31
Apr 266.89
Apr 267.74
Mar 267.25
Mar 267.05
Mar 267.51
Mar 267.72
Feb 267.97
Feb 268.21
Feb 268.08
Feb 267.82
Jan 267.41
Jan 267.23
Jan 267.17
Jan 267.33
Jan 267.36
Dec 257.51
Dec 257.95
Dec 257.6
Dec 257.71
Nov 256.93
Nov 257.17
Nov 257.15
Nov 257.03
Oct 257.32
Oct 257.93
Oct 258.42
Oct 258.01
Oct 258.4
Sep 258.48
Sep 258.05
Sep 258.04
Sep 258.01
Aug 257.85
Aug 258.25
Aug 258.08
Aug 257.94
Aug 257.95
Jul 258.13
Jul 257.84
Jul 257.8
Jul 258.01
Jun 258.07
Jun 257.87
Jun 258.43
Jun 258.66
May 259.3
May 258.92
May 258.77
May 258.34
May 258.38
Apr 258.4
Apr 258.54
Apr 258.49
Apr 258.14
Mar 259.08
Mar 259.23
Mar 2511.07
Mar 2511.68
Feb 2511.37
Feb 2511.11
Feb 2510.96
Feb 2510.81
Jan 2510.87
Jan 2510.75
Jan 2510.58
Jan 2511.2
Jan 2511.83
Dec 2411.96
Dec 2411.82
Dec 2412.27
Dec 2412.17
Nov 2411.99
Nov 2410.99
Nov 2411.29
Nov 2411.34
Nov 2410.98
Oct 2410.91
Oct 2410.37
Free Cash Flow Yield
10%15%20%25%30%med 23.31%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SDXAY Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 2615.4%
Sep 2614.99%
Aug 2614.86%
Aug 2615.45%
Aug 2615.36%
Aug 2615.19%
Jul 2615.18%
Jul 2615.68%
Jul 2615.97%
Jul 2616.46%
Jul 2616.19%
Jun 2617.02%
Jun 2616.6%
Jun 2617.24%
Jun 2617.42%
May 2618.23%
May 2623.32%
May 2622.56%
May 2625.01%
May 2624.43%
Apr 2624.58%
Apr 2624.96%
Apr 2626.48%
Apr 2623.56%
Mar 2625.14%
Mar 2625.89%
Mar 2624.29%
Mar 2623.62%
Feb 2622.88%
Feb 2622.22%
Feb 2622.58%
Feb 2623.31%
Jan 2624.63%
Jan 2625.22%
Jan 2625.44%
Jan 2624.89%
Jan 2624.77%
Dec 2524.28%
Dec 2522.95%
Dec 2524%
Dec 2523.64%
Nov 2527.99%
Nov 2527.04%
Nov 2527.12%
Nov 2527.6%
Oct 2526.51%
Oct 2524.47%
Oct 2523.05%
Oct 2524.22%
Oct 2523.1%
Sep 2522.88%
Sep 2524.11%
Sep 2524.14%
Sep 2524.22%
Aug 2524.71%
Aug 2523.52%
Aug 2524.01%
Aug 2524.43%
Aug 2524.4%
Jul 2523.87%
Jul 2524.76%
Jul 2524.88%
Jul 2524.22%
Jun 2524.03%
Jun 2524.65%
Jun 2523.03%
Jun 2522.4%
May 2520.87%
May 2524.41%
May 2524.83%
May 2526.12%
May 2526%
Apr 2525.93%
Apr 2525.51%
Apr 2525.66%
Apr 2526.75%
Mar 2524%
Mar 2523.61%
Mar 2519.69%
Mar 2518.66%
Feb 2519.16%
Feb 2519.6%
Feb 2519.88%
Feb 2520.16%
Jan 2520.05%
Jan 2520.27%
Jan 2520.59%
Jan 2519.45%
Jan 2518.42%
Dec 2418.22%
Dec 2418.43%
Dec 2417.76%
Dec 2417.9%
Nov 2418.17%
Nov 2415.69%
Nov 2415.28%
Nov 2415.2%
Nov 2415.71%
Oct 2415.8%
Oct 2416.63%
Price to Sales
0.10.150.20.250.3med 0.16Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SDXAY Price to Sales by quarter
PeriodPrice to Sales
Sep 260.17
Sep 260.18
Aug 260.18
Aug 260.17
Aug 260.17
Aug 260.18
Jul 260.18
Jul 260.17
Jul 260.17
Jul 260.16
Jul 260.16
Jun 260.16
Jun 260.16
Jun 260.15
Jun 260.15
May 260.15
May 260.14
May 260.15
May 260.13
May 260.13
Apr 260.13
Apr 260.13
Apr 260.12
Apr 260.14
Mar 260.13
Mar 260.13
Mar 260.14
Mar 260.14
Feb 260.14
Feb 260.15
Feb 260.15
Feb 260.14
Jan 260.13
Jan 260.13
Jan 260.13
Jan 260.13
Jan 260.13
Dec 250.14
Dec 250.14
Dec 250.14
Dec 250.14
Nov 250.14
Nov 250.15
Nov 250.15
Nov 250.14
Oct 250.15
Oct 250.16
Oct 250.17
Oct 250.16
Oct 250.17
Sep 250.17
Sep 250.16
Sep 250.16
Sep 250.16
Aug 250.16
Aug 250.17
Aug 250.16
Aug 250.16
Aug 250.16
Jul 250.17
Jul 250.16
Jul 250.16
Jul 250.16
Jun 250.16
Jun 250.16
Jun 250.17
Jun 250.18
May 250.19
May 250.18
May 250.18
May 250.17
May 250.17
Apr 250.17
Apr 250.18
Apr 250.18
Apr 250.17
Mar 250.19
Mar 250.19
Mar 250.23
Mar 250.24
Feb 250.24
Feb 250.23
Feb 250.23
Feb 250.22
Jan 250.23
Jan 250.22
Jan 250.22
Jan 250.23
Jan 250.25
Dec 240.25
Dec 240.24
Dec 240.25
Dec 240.25
Nov 240.25
Nov 240.26
Nov 240.27
Nov 240.27
Nov 240.26
Oct 240.26
Oct 240.25
EV/EBITDA
3456med 4.1Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SDXAY EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 264.25
Sep 264.33
Aug 264.35
Aug 264.24
Aug 264.26
Aug 264.29
Jul 264.29
Jul 264.2
Jul 264.15
Jul 264.07
Jul 264.12
Jun 263.99
Jun 264.05
Jun 263.95
Jun 263.93
May 263.82
May 263.41
May 263.48
May 263.26
May 263.31
Apr 263.3
Apr 263.27
Apr 263.15
Apr 263.39
Mar 263.25
Mar 263.19
Mar 263.32
Mar 263.38
Feb 263.45
Feb 263.51
Feb 263.48
Feb 263.41
Jan 263.29
Jan 263.25
Jan 263.23
Jan 263.27
Jan 263.28
Dec 253.32
Dec 253.44
Dec 253.35
Dec 253.38
Nov 253.78
Nov 253.86
Nov 253.85
Nov 253.81
Oct 253.9
Oct 254.11
Oct 254.27
Oct 254.14
Oct 254.27
Sep 254.29
Sep 254.15
Sep 254.15
Sep 254.14
Aug 254.08
Aug 254.22
Aug 254.16
Aug 254.11
Aug 254.12
Jul 254.18
Jul 254.08
Jul 254.07
Jul 254.14
Jun 254.16
Jun 254.09
Jun 254.27
Jun 254.35
May 254.57
May 254
May 253.95
May 253.81
May 253.82
Apr 253.83
Apr 253.87
Apr 253.86
Apr 253.74
Mar 254.05
Mar 254.09
Mar 254.69
Mar 254.88
Feb 254.78
Feb 254.7
Feb 254.65
Feb 254.6
Jan 254.62
Jan 254.58
Jan 254.53
Jan 254.73
Jan 254.93
Dec 244.97
Dec 244.93
Dec 245.07
Dec 245.04
Nov 244.99
Nov 245.29
Nov 245.4
Nov 245.42
Nov 245.29
Oct 245.27
Oct 245.07
Price/Operating Cashflow
2345med 3.21Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SDXAY Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 264.2
Sep 264.32
Aug 264.35
Aug 264.19
Aug 264.21
Aug 264.26
Jul 264.26
Jul 264.13
Jul 264.05
Jul 263.93
Jul 264
Jun 263.8
Jun 263.9
Jun 263.75
Jun 263.71
May 263.55
May 262.97
May 263.06
May 262.77
May 262.83
Apr 262.81
Apr 262.77
Apr 262.61
Apr 262.94
Mar 262.75
Mar 262.67
Mar 262.85
Mar 262.93
Feb 263.02
Feb 263.11
Feb 263.06
Feb 262.97
Jan 262.81
Jan 262.74
Jan 262.72
Jan 262.78
Jan 262.79
Dec 252.85
Dec 253.01
Dec 252.88
Dec 252.92
Nov 252.76
Nov 252.85
Nov 252.84
Nov 252.8
Oct 252.91
Oct 253.15
Oct 253.35
Oct 253.19
Oct 253.34
Sep 253.37
Sep 253.2
Sep 253.2
Sep 253.19
Aug 253.12
Aug 253.28
Aug 253.21
Aug 253.16
Aug 253.16
Jul 253.23
Jul 253.12
Jul 253.1
Jul 253.19
Jun 253.21
Jun 253.13
Jun 253.35
Jun 253.45
May 253.7
May 253.18
May 253.13
May 252.98
May 252.99
Apr 253
Apr 253.05
Apr 253.03
Apr 252.91
Mar 253.24
Mar 253.29
Mar 253.95
Mar 254.17
Feb 254.06
Feb 253.97
Feb 253.91
Feb 253.86
Jan 253.88
Jan 253.84
Jan 253.78
Jan 254
Jan 254.22
Dec 244.27
Dec 244.22
Dec 244.38
Dec 244.34
Nov 244.28
Nov 244.8
Nov 244.93
Nov 244.95
Nov 244.79
Oct 244.77
Oct 244.53
Price to Book
11.522.533.5med 2Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SDXAY Price to Book by quarter
PeriodPrice to Book
Sep 262.26
Sep 262.33
Aug 262.35
Aug 262.26
Aug 262.27
Aug 262.3
Jul 262.3
Jul 262.22
Jul 262.18
Jul 262.12
Jul 262.15
Jun 262.05
Jun 262.1
Jun 262.02
Jun 262
May 261.91
May 261.5
May 261.55
May 261.4
May 261.44
Apr 261.43
Apr 261.41
Apr 261.32
Apr 261.49
Mar 261.4
Mar 261.36
Mar 261.44
Mar 261.49
Feb 261.53
Feb 261.58
Feb 261.55
Feb 261.5
Jan 261.42
Jan 261.39
Jan 261.38
Jan 261.41
Jan 261.42
Dec 251.44
Dec 251.53
Dec 251.46
Dec 251.48
Nov 251.65
Nov 251.71
Nov 251.7
Nov 251.67
Oct 251.74
Oct 251.89
Oct 252
Oct 251.91
Oct 252
Sep 252.02
Sep 251.91
Sep 251.91
Sep 251.91
Aug 251.87
Aug 251.96
Aug 251.92
Aug 251.89
Aug 251.89
Jul 251.93
Jul 251.86
Jul 251.85
Jul 251.91
Jun 251.92
Jun 251.87
Jun 252
Jun 252.06
May 252.21
May 252.26
May 252.22
May 252.11
May 252.12
Apr 252.13
Apr 252.16
Apr 252.15
Apr 252.06
Mar 252.3
Mar 252.34
Mar 252.8
Mar 252.96
Feb 252.88
Feb 252.82
Feb 252.78
Feb 252.74
Jan 252.75
Jan 252.72
Jan 252.68
Jan 252.84
Jan 253
Dec 243.03
Dec 243
Dec 243.11
Dec 243.08
Nov 243.04
Nov 242.67
Nov 242.75
Nov 242.76
Nov 242.67
Oct 242.66
Oct 242.52
Sodexo S.A.
SDXAY
Stockpicker

Video analysis: SDXAY

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: SDXAY

Sodexo S.A. Sponsored ADR (OTCMKTS:SDXAY) Receives Consensus Recommendation of “Reduce” from Brokerages

defenseworld.net · 9 Sep 2026

Sodexo S.A. Sponsored ADR (OTCMKTS:SDXAY) Receives Consensus Recommendation of “Reduce” from Brokerages

Shares of Sodexo S.A. Sponsored ADR (OTCMKTS:SDXAY - Get Free Report) have been given a consensus recommendation of "Reduce" by the nine research firms that are presently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, six have given a hold recommendation and one has assigned

Sodexo S.A. Sponsored ADR (OTCMKTS:SDXAY) Short Interest Down 36.8% in August

defenseworld.net · 31 Aug 2026

Sodexo S.A. Sponsored ADR (OTCMKTS:SDXAY) Short Interest Down 36.8% in August

Sodexo S.A. Sponsored ADR (OTCMKTS:SDXAY - Get Free Report) was the target of a significant decline in short interest in August. As of August 14th, there was short interest totaling 30,367 shares, a decline of 36.8% from the July 30th total of 48,013 shares. Based on an average trading volume of 289,753 shares, the days-to-cover

Pittsburg State University Partners with Sodexo to Enhance Campus Dining Ahead of Fall Semester

businesswire.com · 12 Aug 2026

Pittsburg State University Partners with Sodexo to Enhance Campus Dining Ahead of Fall Semester

NORTH BETHESDA, Md.--(BUSINESS WIRE)--As the 2026–27 academic year approaches, Sodexo and Pittsburg State University are launching a new partnership designed to elevate the campus dining experience with innovative concepts, expanded choices and solutions tailored to the needs of the campus community. Pitt State selected Sodexo for its collaborative approach, deep expertise in higher education dining and commitment to creating engaging food experiences that bring students, employees and visitors.

Sodexo's Clinicia Sets the Standard for the Future of Patient Nutrition

businesswire.com · 30 Jul 2026

Sodexo's Clinicia Sets the Standard for the Future of Patient Nutrition

NORTH BETHESDA, Md.--(BUSINESS WIRE)--Sodexo today announced that Clinicia, its evidence-based patient nutrition program, is now helping 500 hospitals across the United States deliver 10 million personalized, clinically appropriate patient meals annually through 1,600 recipes, more than 80 therapeutic diets and the analysis of more than 175,000 menu data points each year – a reach that continues to grow. “Healthcare is redefining the role nutrition plays in patient care,” said Molly Matthews, C.

Sodexo S.A. (SDXAY) Discusses Strategic Roadmap and Medium-Term Ambitions for Growth and Competitiveness Transcript

seekingalpha.com · 16 Jul 2026

Sodexo S.A. (SDXAY) Discusses Strategic Roadmap and Medium-Term Ambitions for Growth and Competitiveness Transcript

Sodexo S.A. (SDXAY) Discusses Strategic Roadmap and Medium-Term Ambitions for Growth and Competitiveness Transcript

Sodexo: Upgrade To Buy As Q3 Sales Beat Supports A Turnaround Re-Rating

seekingalpha.com · 11 Jul 2026

Sodexo: Upgrade To Buy As Q3 Sales Beat Supports A Turnaround Re-Rating

Q3 organic revenue grew 2%, beating consensus, with notable strength in Rest of World (+10.6%) and stable-to-positive commercial trends. Management raised full-year sales outlook to 1.2–1.5% growth, while EBIT margin guidance remains unchanged; Q4 guidance appears overly conservative. We believe Sodexo is shifting from an execution-risk story to a self-help recovery story.

Sodexo S.A. (SDXAY) Q3 2026 Sales/Trading Call Transcript

seekingalpha.com · 2 Jul 2026

Sodexo S.A. (SDXAY) Q3 2026 Sales/Trading Call Transcript

Sodexo S.A. (SDXAY) Q3 2026 Sales/Trading Call Transcript

Sodexo Shares Rise on Strong Revenue Growth, Raised Outlook

wsj.com · 2 Jul 2026

Sodexo Shares Rise on Strong Revenue Growth, Raised Outlook

Shares rose 6.8% following a strong third-quarter and an upgraded organic revenue growth forecast for the fiscal year.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.